Sort by
Medicine and Dentistry
Activated Clotting Time
20%
Acute Coronary Syndrome
8%
Anticoagulant
9%
Anticoagulation
32%
Antithrombotic
20%
Apixaban
9%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
30%
Biological Marker
30%
Blood Clotting Factor 10a Inhibitor
15%
Bone Mass
30%
Brain Natriuretic Peptide
17%
C Reactive Protein
8%
Catheter Ablation
78%
Catheter Ablation
22%
Creatinine
12%
Cryoablation
18%
Dabigatran
30%
Event Free Survival
6%
Fibrinolysis
6%
Heart Failure
30%
Heart Left Atrium Pressure
6%
Heart Left Ventricle Ejection Fraction
34%
Heart Rate Variability
8%
Inflammatory Cytokine
8%
Interleukin 6
8%
Intracardiac Echocardiography
30%
Left Ventricular Systolic Dysfunction
9%
Lower Limb
12%
Magnetic Resonance Imaging
12%
Multivariate Analysis
12%
Muscle Atrophy
8%
Persistent Atrial Fibrillation
30%
Protein Degradation
30%
Pulmonary Vein Isolation
94%
Repolarization
12%
Skeletal Muscle
30%
Systolic Heart Failure
30%
T Wave
30%
T Wave Amplitude
21%
Tachycardia
6%
Thromboembolism
16%
Ventricular Fibrillation
30%
Ventricular Tachycardia
30%
Vitamin K Antagonist
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
30%
Anticoagulant Agent
22%
Antivitamin K
15%
Apixaban
9%
Atrial Fibrillation
90%
Biological Marker
30%
Bleeding
6%
Brain Natriuretic Peptide
17%
C Reactive Protein
8%
Cardiovascular Disease
30%
Creatine Kinase MB
6%
Creatinine
12%
Cytokine
8%
D Dimer
6%
Heart Failure
30%
Heart Muscle Injury
12%
Inflammation
42%
Interleukin 6
8%
Left Ventricular Systolic Dysfunction
30%
Muscle Atrophy
8%
Non Insulin Dependent Diabetes Mellitus
30%
Paroxysmal Atrial Fibrillation
12%
Plasmin
6%
Plasmin Inhibitor
6%
Prothrombin
6%
Rivaroxaban
30%
Systolic Heart Failure
30%
Thromboembolism
25%
Troponin I
6%
Keyphrases
Ablation Index
30%
Activated Clotting Time
20%
AF Recurrence
11%
Apixaban
9%
Atrial Fibrillation Progression
30%
Coagulation Biomarkers
30%
Effectiveness Comparison
30%
Force-time Integral
22%
Impedance Drop
30%
Intracardiac Echocardiography
30%
Multiple Wavelet
30%
Persistent AF
9%
Prognostic Role
5%
Random Forest Method
5%
Random Forest Regression
5%
Silent Cerebral Infarction
15%
Skeletal muscle Proteolysis
30%
Small RNA Sequencing
30%
Stable Cardiovascular Disease
30%
TBX5 Gene
8%
Time Kinetics
5%